13D/13G Filings - FARALLON CAPITAL PARTNERS LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-17
3:20 pm
Purchase
2023-02-08 13G AVROBIO, Inc.
AVRO
FARALLON CAPITAL PARTNERS LP 259,667
7.100%
259,667increase
(New Position)
Filing
History
2023-02-14
08:27 am
Sale
2022-12-31 13G Beam Therapeutics Inc.
BEAM
FARALLON CAPITAL PARTNERS LP 3,399,921
4.800%
-151,850decrease
(-4.28%)
Filing
History
2023-02-09
4:55 pm
Unchanged
2022-12-31 13G Shelter Acquisition Corporation I
SHQA
FARALLON CAPITAL PARTNERS LP 0
0.000%
0
(Unchanged)
Filing
History
2023-02-09
4:55 pm
Purchase
2022-12-31 13G Swiftmerge Acquisition Corp.
IVCP
FARALLON CAPITAL PARTNERS LP 2,205,000
9.700%
2,205,000increase
(New Position)
Filing
History
2023-02-09
4:54 pm
Purchase
2022-12-31 13G Protagonist Therapeutics, Inc.
PTGX
FARALLON CAPITAL PARTNERS LP 5,055,102
9.990%
5,055,102increase
(New Position)
Filing
History
2023-02-07
5:10 pm
Sale
2022-12-31 13G Better Therapeutics, Inc.
BTTX
FARALLON CAPITAL PARTNERS LP 813,556
3.400%
-536,444decrease
(-39.74%)
Filing
History
2023-02-07
5:09 pm
Sale
2022-12-31 13G Clarivate Plc
CLVT
FARALLON CAPITAL PARTNERS LP 15,177,433
2.300%
-20,148,467decrease
(-57.04%)
Filing
History
2023-02-07
5:09 pm
Purchase
2022-12-31 13G AMYRIS INC
AMRSQ
FARALLON CAPITAL PARTNERS LP 1,000,000
0.300%
1,000,000increase
(New Position)
Filing
History
2023-02-06
4:20 pm
Unchanged
2022-12-31 13G SEP Acquisition Corp.
SEPA
FARALLON CAPITAL PARTNERS LP 0
0.000%
0
(Unchanged)
Filing
History
2023-02-06
09:06 am
Purchase
2022-12-31 13G Enanta Pharmaceuticals, Inc.
ENTA
FARALLON CAPITAL PARTNERS LP 1,550,000
7.500%
1,550,000increase
(New Position)
Filing
History
2023-02-03
5:16 pm
Purchase
2022-12-31 13G Savara Inc.
SVRA
FARALLON CAPITAL PARTNERS LP 11,532,622
9.990%
11,532,622increase
(New Position)
Filing
History
2023-02-03
5:15 pm
Purchase
2022-12-31 13G Longboard Pharmaceuticals, Inc.
LBPH
FARALLON CAPITAL PARTNERS LP 1,417,917
9.990%
1,417,917increase
(New Position)
Filing
History
2023-02-03
5:15 pm
Sale
2022-12-31 13G Aramark
ARMK
FARALLON CAPITAL PARTNERS LP 14,998,004
4.200%
-7,593,263decrease
(-33.61%)
Filing
History
2023-02-01
5:16 pm
Sale
2022-12-31 13G Imago BioSciences, Inc.
IMGO
FARALLON CAPITAL PARTNERS LP 0
0.000%
-2,671,313decrease
(Position Closed)
Filing
History
2023-02-01
5:12 pm
Purchase
2022-12-31 13G Generation Bio Co.
GBIO
FARALLON CAPITAL PARTNERS LP 1,249,382
2.100%
1,249,382increase
(New Position)
Filing
History
2023-02-01
5:09 pm
Unchanged
2022-12-31 13G Big Sky Growth Partners, Inc.
BSKYW
FARALLON CAPITAL PARTNERS LP 0
0.000%
0
(Unchanged)
Filing
History
2023-01-31
5:18 pm
Purchase
2022-12-31 13G Disruptive Acquisition Corporation I
DISA
FARALLON CAPITAL PARTNERS LP 1,400,000
5.100%
1,400,000increase
(New Position)
Filing
History
2023-01-31
5:14 pm
Purchase
2022-12-31 13G Berenson Acquisition Corp. I
BACA
FARALLON CAPITAL PARTNERS LP 2,662,500
9.600%
2,662,500increase
(New Position)
Filing
History
2023-01-31
5:09 pm
Unchanged
2022-12-31 13G ARYA Sciences Acquisition Corp IV
ARYD
FARALLON CAPITAL PARTNERS LP 800,000
5.200%
0
(Unchanged)
Filing
History
2022-10-07
3:12 pm
Purchase
2022-09-29 13D Change Healthcare Inc.
CHNG
FARALLON CAPITAL PARTNERS LP 18,076,272
5.500%
18,076,272increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, Next